Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PNT2258 in Richter's Transformation
NCT02378038Phase 2Terminated
- Sponsor
- GSK
- Start
- Aug 2015
- Primary completion
- Jun 2016
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), Targeted Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of PNT2258 in Richter's transformation (RT), sponsored by GSK. Started Aug 2015; status: terminated.
02
Drugs
PNT2258
03
Conditions
Richter's transformation (RT)
Beyond the preview
Go deeper on NCT02378038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02378038.